- Home
*Standard Abstract Submission is OPEN!*
Put a Spotlight on Your Innovative Research!
The CRS 2025 Annual Meeting and Exposition offers an exceptional opportunity to share your research with an international audience of experts in the design, development, and implementation of novel delivery technologies.
All abstracts submitted for the CRS 2025 Annual Meeting & Exposition will go through a rigorous review procedure to maintain the highest scientific quality of the meeting. All abstracts will be evaluated by the CRS Annual Meeting Program Committee and will be assigned a rank order based on their scientific content.
Standard Abstract Submissions
Some abstracts will be selected for oral presentations during regular scientific sessions. Each scientific session will include invited speakers and several oral presentations that are selected from the submitted abstracts. A moderated discussion will follow at the end of these sessions. There will also be poster presentations available for viewing during the Annual Meeting and Exposition.
Abstracts will be rejected if they do not comply with minimum submission instructions, do not follow the proper format, and/or do not include all required fields.
Type of Presentation
Standard abstract submissions will be eligible for oral or poster presentations during the Annual Meeting & Exposition.
Submitted Abstracts Must Meet the Following Minimum Requirements:
- Significant and original contribution within the scope of the Controlled Release Society.
- Abstract submitted by the deadline.
- Written in clear English with minimum syntax/spelling errors.
- Minimum syntax/spelling mistakes.
- Sufficient data presented, adequately analyzed, and discussed with appropriate conclusions supported by the data.
- Meets format guidelines.
Process for Abstract Submission:
- Abstracts should contain a substantial portion of unpublished data.
- The criterion for acceptance of presentation at the CRS Annual Meeting & Exposition is based on a peer-review process.
- The authors must obtain any necessary permissions before submission of the abstract.
- The CRS Annual Meeting Program Committee reserves the right to evaluate, accept, or reject any submitted abstract. The committee will determine the status (accept or reject) of all submitted abstracts and the placement (oral or poster presentation) of all accepted abstracts. The committee may also switch abstracts to any topic category based on their evaluation and organization requirements.
Session Topics and Descriptions for Abstracts
- Nanomedicine and Nanoscale Delivery (Focus Group - NND): Development, physicochemical and biological characterization, in vivo validation, delivery of therapeutics, functionalization with active-targeting moieties, long-acting formulations, controlled release, injectables, implantables.
- Immuno Delivery (Focus Group - ID): Targeting immune cells in peripheral tissues and at the sites of immunological reactions, modification of the innate and adaptive immunity, immunomodulation of the tumor microenvironment, immunotherapy.
- Oral Delivery (Focus Group - OrD): Formulation and manufacturing of molecules and biologics to maximize their oral bioavailability, oral delivery of nutraceuticals and food additives, food and beverages as delivery vehicles.
- Skin and Mucosal Delivery (Focus Group - SMD): Delivery of therapeutic and diagnostic agents through skin or mucous membranes (gastrointestinal tract, respiratory tract, other tissues with mucosal lining), strategies to overcome challenges in topical, subcutaneous, transdermal, intradermal, intramuscular, and mucosal delivery.
- Ocular Delivery (Focus Group - OcD): Drug delivery systems for vision-threatening diseases, drug-device combinations (e.g., contact lenses, punctal plugs, injectables, intravitreal devices, suprachoroidal delivery, ultrasound-mediated delivery), overcoming physiological barriers in ocular drug delivery.
- Bioengineering (Focus Group – Bioengineering): Bioinspired and biomimetic strategies for the design of drug delivery systems (e.g., cell-mimicking carriers, synthetic extracellular vesicles), construction of biological building blocks, leveraging bio-interactions to create delivery platforms, mimicking the properties of natural particles, high concentration (nano)biologics.
- Gene Delivery and Gene Editing (Focus Group - GDGE): Delivery of nucleic acids (mRNA, pDNA, oligonucleotides) with nanoformulations, modulation of protein expression, genome editing, vaccination, overcoming biological limitations (e.g., endosomal escape, cellular targeting, biodistribution).
- Delivery to the Nervous System: Systems for delivering therapeutic agents to the central and peripheral nervous system, blood-brain barrier (BBB) and blood-nerve barrier (BNB) crossing, intrathecal, intracranial, intracerebroventricular, and nasal administration, focused ultrasound.
- Alternative Methods to Animal Testing: Organs-on-a-chip, bioreactors, microfluidic devices, three-dimensional cell assemblies, in vitro recreation of the biological complexity, 3D bioprinting, in vitro / in silico assays to characterize the efficacy, specificity, and toxicity of therapeutic agents.
- Imaging in Drug Delivery: Imaging of drug delivery for monitoring disease progression, biodistribution, nanoparticle kinetics, image-guided drug delivery (TACE, SIRT, HIFU, etc), theranostics, companion diagnostics, image-guided patient stratification.
- Artificial Intelligence and Predictive Models: Convergence of drug delivery with artificial intelligence, machine learning, mathematical modeling (PK, PD, compartment modeling), tools for material selection and optimization of pharmacological and biological performance of delivery systems, modeling of biophysical processes (e.g., cell uptake, mass transport, biodistribution, biodegradation, etc).
- Manufacturing and Process Scale-Up: Evaluation and characterization of delivery products, preparation and scale-up, Quality-by-design (QbD), Quality Control (QC), analytical technologies, additive manufacturing, continuous manufacturing, delivery devices, 3D-printing, green technologies (e.g., natural, non-modified, renewable materials).
- Delivery Technologies for Diversified Products: Personal and home care areas (cosmetics, skincare, deodorants, antiperspirants, hair care, mouth care, air fresheners, cleaning and sanitizing agents), household products, industrial applications (paints, coatings, batteries, green energy, etc.), textiles, space applications, sustainable agriculture, aquaculture, farming.
- Global Health, Special Population, and Women's Health: Solutions for drug shortage, drug-agnostic clinical development, emerging technology / regulatory programs, solutions and management of global diseases, diseases affecting developing countries, gender/race-related health with emphasis on women, vulnerable pediatric and geriatric patients, minorities.
Standard Abstract Submission Deadline: January 6, 2025
Countdown to Philadelphia!
